Ads
related to: pulmonary therapy to strengthen lungs and arteries function- Prescribing Information
Download Prescribing Information
For FDA Approved Ohtuvayre.
- Download Resources
Download Important Resources For
Your Patients & Your Practice.
- Clinical Efficacy Data
See Study Results & Efficacy Data
For FDA Approved Ohtuvayre.
- Request A Rep
Request A Rep To Learn More About
Ohtuvayre, An FDA Approved Therapy.
- Prescribing Information
Search results
Results From The WOW.Com Content Network
Pulmonary rehabilitation, also known as respiratory rehabilitation, is an important part of the management and health maintenance of people with chronic respiratory disease who remain symptomatic or continue to have decreased function despite standard medical treatment. It is a broad therapeutic concept.
Nonspecific signs may include pain, swelling, redness, warmness, and engorged superficial veins. Pulmonary embolism, a potentially life-threatening complication, is caused by the detachment (embolization) of a clot that travels to the lungs. Together, DVT and pulmonary embolism constitute a single disease process known as venous thromboembolism.
Second, to specifically improve ventilation to areas of local lung obstruction. If the objectives of the chest physiotherapy are achieved, an increase in local lung expansion should occur, and a parallel increase in perfusion to the affected area would result.
This mainly disrupts the organised thrombus and to a lesser degree presses it against the walls of the arteries. [9] This increases the size of the lumen of the arteries, thus opening them and allowing the blood flow to be restored. [9] The balloon is then deflated and removed. [8] A number of arteries can be treated during each BPA procedure. [8]
Bronchial artery is considered dilated when its diameter is more than 2 mm. Several causes of bronchial artery dilatations are: congenital heart or lung diseases, obstructions of pulmonary artery, and lung inflammation. [1] The bronchial arteries are typically enlarged and tortuous in chronic pulmonary thromboembolic hypertension. [3]
Treatment with supplemental oxygen may improve their well-being; alternatively, in some this can lead to the adverse effect of elevating the carbon dioxide content in the blood (hypercapnia) to levels that may become toxic. [3] [4] With normal lung function, a stimulation to take another breath occurs when a patient has a slight rise in PaCO 2.